Medicine Description bonprove 150 mg
Bonprove 150 mg tablet is a medication that contains ibandronic acid, a bisphosphonate that primarily works by inhibiting the activity of osteoclasts, the cells responsible for bone resorption. By decreasing osteoclast-mediated bone breakdown, ibandronic acid leads to a net gain in bone density and strength. This action not only helps to maintain bone integrity but also reduces the risk of osteoporotic fractures, particularly in populations at higher risk, such as postmenopausal women. Ibandronic acid achieves this by binding to hydroxyapatite in bone tissue, which enhances its retention and effectiveness while preventing the loss of bone mass.
Indications and Uses of Bonprove 150 mg tablet
- Treatment of osteoporosis in postmenopausal women
- Prevention of osteoporotic fractures
- Management of glucocorticoid-induced osteoporosis
Side Effects of Bonprove 150 mg tablet
- Gastrointestinal disturbances (nausea, abdominal pain)
- Musculoskeletal pain
- Esophagitis or esophageal ulcers
- Hypocalcemia
- Acute phase reactions (fever, flu-like symptoms)
Storage and Handling
Store Bonprove 150 mg tablets at room temperature, away from moisture and heat. Keep the medication in its original packaging to protect it from light. Ensure it is out of reach of children and pets.
Patient Advice and Precautions
Prior to beginning treatment, inform your healthcare provider of any existing health conditions or medications you are taking. It is crucial to maintain adequate hydration and ensure sufficient calcium and vitamin D intake while on treatment. Regular follow-ups with your healthcare provider are important for monitoring bone health. Be aware of any signs of allergic reactions or severe side effects, and seek medical attention if they occur.